BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 27365378)

  • 1. Expression of microRNAs of C19MC in Different Histological Types of Testicular Germ Cell Tumour.
    Flor I; Spiekermann M; Löning T; Dieckmann KP; Belge G; Bullerdiek J
    Cancer Genomics Proteomics; 2016; 13(4):281-9. PubMed ID: 27365378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA miR-371a-3p in serum of patients with germ cell tumours: evaluations for establishing a serum biomarker.
    Spiekermann M; Belge G; Winter N; Ikogho R; Balks T; Bullerdiek J; Dieckmann KP
    Andrology; 2015 Jan; 3(1):78-84. PubMed ID: 25187505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated Microarray-Based Data Analysis of miRNA Expression Profiles: Identification of Novel Biomarkers of Cisplatin-Resistance in Testicular Germ Cell Tumours.
    Roška J; Lobo J; Ivovič D; Wachsmannová L; Mueller T; Henrique R; Jerónimo C; Chovanec M; Jurkovičová D
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-371a-3p Serum Levels Are Increased in Recurrence of Testicular Germ Cell Tumor Patients.
    Terbuch A; Adiprasito JB; Stiegelbauer V; Seles M; Klec C; Pichler GP; Resel M; Posch F; Lembeck AL; Stöger H; Szkandera J; Pummer K; Bauernhofer T; Hutterer GC; Gerger A; Stotz M; Pichler M
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30321995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germ cell tumour subtypes display differential expression of microRNA371a-3p.
    Vilela-Salgueiro B; Barros-Silva D; Lobo J; Costa AL; Guimarães R; Cantante M; Lopes P; Braga I; Oliveira J; Henrique R; Jerónimo C
    Philos Trans R Soc Lond B Biol Sci; 2018 Jun; 373(1748):. PubMed ID: 29685967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testicular germ cell tumour cells release microRNA-containing extracellular vesicles that induce phenotypic and genotypic changes in cells of the tumour microenvironment.
    Alonso-Crisostomo L; Trendell J; Ferraresso M; Bailey S; Ward D; Scurlock ZGL; Wenlock SC; Bastos CAP; Jugdaohsingh R; Faria NJ; Enright AJ; Scarpini CG; Coleman N; Murray MJ
    Int J Cancer; 2024 Jan; 154(2):372-388. PubMed ID: 37632231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of miR-514a-3p regulation of PEG3 activates the NF-kappa B pathway in human testicular germ cell tumors.
    Özata DM; Li X; Lee L; Liu J; Warsito D; Hajeri P; Hultman I; Fotouhi O; Marklund S; Ährlund-Richter L; Juhlin CC; Larsson C; Lui WO
    Cell Death Dis; 2017 May; 8(5):e2759. PubMed ID: 28471449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs miR-371-3 in serum as diagnostic tools in the management of testicular germ cell tumours.
    Dieckmann KP; Spiekermann M; Balks T; Flor I; Löning T; Bullerdiek J; Belge G
    Br J Cancer; 2012 Nov; 107(10):1754-60. PubMed ID: 23059743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-suppressive function of protein-tyrosine phosphatase non-receptor type 23 in testicular germ cell tumors is lost upon overexpression of miR142-3p microRNA.
    Tanaka K; Kondo K; Kitajima K; Muraoka M; Nozawa A; Hara T
    J Biol Chem; 2013 Aug; 288(33):23990-9. PubMed ID: 23843459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miRNA-302s may act as oncogenes in human testicular germ cell tumours.
    Das MK; Evensen HSF; Furu K; Haugen TB
    Sci Rep; 2019 Jun; 9(1):9189. PubMed ID: 31235829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of miRNA in Testicular Cancer: Current Insights and Future Perspectives.
    Ditonno F; Franco A; Manfredi C; Fasanella D; Abate M; La Rocca R; Crocerossa F; Iossa V; Falagario UG; Cirillo L; Altieri VM; Di Mauro E; Crocetto F; Barone B; Cilio S; Pandolfo SD; Aveta A; Mirone V; Franzese CA; Arcaniolo D; Napolitano L
    Medicina (Kaunas); 2023 Nov; 59(11):. PubMed ID: 38004082
    [No Abstract]   [Full Text] [Related]  

  • 12. Can germ cell neoplasia in situ be diagnosed by measuring serum levels of microRNA371a-3p?
    Radtke A; Cremers JF; Kliesch S; Riek S; Junker K; Mohamed SA; Anheuser P; Belge G; Dieckmann KP
    J Cancer Res Clin Oncol; 2017 Nov; 143(11):2383-2392. PubMed ID: 28819887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating serum miRNA (miR-367-3p, miR-371a-3p, miR-372-3p and miR-373-3p) as biomarkers in patients with testicular germ cell cancer.
    Syring I; Bartels J; Holdenrieder S; Kristiansen G; Müller SC; Ellinger J
    J Urol; 2015 Jan; 193(1):331-7. PubMed ID: 25046619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The metastatic potential of seminomatous germ cell tumours is associated with a specific microRNA pattern.
    Ernst S; Heinzelmann J; Bohle RM; Weber G; Stöckle M; Junker K; Heinzelbecker J
    Andrology; 2020 Nov; 8(6):1687-1698. PubMed ID: 32530514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of piRNA biogenesis and function in testicular germ cell tumors and their precursor germ cell neoplasia in situ.
    Gainetdinov IV; Skvortsova YV; Kondratieva SA; Klimov A; Tryakin AA; Azhikina TL
    BMC Cancer; 2018 Jan; 18(1):20. PubMed ID: 29301509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NANOG controls testicular germ cell tumour stemness through regulation of MIR9-2.
    Cardenas RP; Zyoud A; McIntyre A; Alberio R; Mongan NP; Allegrucci C
    Stem Cell Res Ther; 2024 May; 15(1):128. PubMed ID: 38693576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNAs in Testicular Germ Cell Tumors: The Teratoma Challenge.
    Yodkhunnatham N; Pandit K; Puri D; Yuen KL; Bagrodia A
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of microRNA-371a-3p are not elevated in testicular tumours of non-germ cell origin.
    Belge G; Grobelny F; Radtke A; Bodes J; Matthies C; Wülfing C; Dieckmann KP
    J Cancer Res Clin Oncol; 2021 Feb; 147(2):435-443. PubMed ID: 33200255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study.
    Dieckmann KP; Radtke A; Geczi L; Matthies C; Anheuser P; Eckardt U; Sommer J; Zengerling F; Trenti E; Pichler R; Belz H; Zastrow S; Winter A; Melchior S; Hammel J; Kranz J; Bolten M; Krege S; Haben B; Loidl W; Ruf CG; Heinzelbecker J; Heidenreich A; Cremers JF; Oing C; Hermanns T; Fankhauser CD; Gillessen S; Reichegger H; Cathomas R; Pichler M; Hentrich M; Eredics K; Lorch A; Wülfing C; Peine S; Wosniok W; Bokemeyer C; Belge G
    J Clin Oncol; 2019 Jun; 37(16):1412-1423. PubMed ID: 30875280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Levels of MicroRNA371a-3p: A Highly Sensitive Tool for Diagnosing and Staging Testicular Germ Cell Tumours: A Clinical Case Series.
    Anheuser P; Radtke A; Wülfing C; Kranz J; Belge G; Dieckmann KP
    Urol Int; 2017; 99(1):98-103. PubMed ID: 28586780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.